-
Je něco špatně v tomto záznamu ?
Influence of core extension and side chain nature in targeting G-quadruplex structures with perylene monoimide derivatives
N. Busto, J. García-Calvo, JV. Cuevas, A. Herrera, JL. Mergny, S. Pons, T. Torroba, B. García
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- G-kvadruplexy účinky léků MeSH
- imidy chemická syntéza chemie farmakologie MeSH
- kultivované buňky MeSH
- lidé MeSH
- mitochondrie účinky léků MeSH
- molekulární struktura MeSH
- perylen analogy a deriváty chemická syntéza chemie farmakologie MeSH
- proliferace buněk účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A structure-activity relationship (SAR) study in terms of G-quadruplex binding ability and antiproliferative activity of six fluorescent perylenemonoimide (PMIs) derivatives is reported. A positive charge seems to be the key to target G4. This study also reveals the importance of the element substitution in the potential biological activity of PMIs, being the polyethylene glycol (PEG) chains in the peri position responsible for their antiproliferative activity. Among them, the cationic PMI6 with two PEG chains is the most promising compound since its fluorescence is enhanced in the presence of G-quadruplex structures. Moreover, PMI6 binds to the human telomeric G-quadruplex hTelo with high affinity and displays a high antiproliferative potential towards HeLa (cervical adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian adenocarcinoma) cells. Its fate can be followed inside cells thanks to its fluorescent properties: the compound is found to accumulate in the mitochondria.
ARNA Laboratory INSERM U1212 CNRS UMR 5320 IECB University of Bordeaux F 33600 Pessac France
Chemistry Department University of Burgos Pza Misael Bañuelos s n 09001 Burgos Spain
Institute of Biophysics AS CR v v i Kralovopolska 135 612 65 Brno Czech Republic
Molecular Biology Institute of Barcelona IBMB CSIC 08028 Barcelona Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004563
- 003
- CZ-PrNML
- 005
- 20220127145143.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2021.104660 $2 doi
- 035 __
- $a (PubMed)33550073
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Busto, Natalia $u Chemistry Department, University of Burgos, Pza. Misael Bañuelos s/n, 09001 Burgos, Spain. Electronic address: nbusto@ubu.es
- 245 10
- $a Influence of core extension and side chain nature in targeting G-quadruplex structures with perylene monoimide derivatives / $c N. Busto, J. García-Calvo, JV. Cuevas, A. Herrera, JL. Mergny, S. Pons, T. Torroba, B. García
- 520 9_
- $a A structure-activity relationship (SAR) study in terms of G-quadruplex binding ability and antiproliferative activity of six fluorescent perylenemonoimide (PMIs) derivatives is reported. A positive charge seems to be the key to target G4. This study also reveals the importance of the element substitution in the potential biological activity of PMIs, being the polyethylene glycol (PEG) chains in the peri position responsible for their antiproliferative activity. Among them, the cationic PMI6 with two PEG chains is the most promising compound since its fluorescence is enhanced in the presence of G-quadruplex structures. Moreover, PMI6 binds to the human telomeric G-quadruplex hTelo with high affinity and displays a high antiproliferative potential towards HeLa (cervical adenocarcinoma), A549 (lung adenocarcinoma) and A2780 (ovarian adenocarcinoma) cells. Its fate can be followed inside cells thanks to its fluorescent properties: the compound is found to accumulate in the mitochondria.
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a G-kvadruplexy $x účinky léků $7 D054856
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imidy $x chemická syntéza $x chemie $x farmakologie $7 D007094
- 650 _2
- $a mitochondrie $x účinky léků $7 D008928
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a perylen $x analogy a deriváty $x chemická syntéza $x chemie $x farmakologie $7 D010569
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a García-Calvo, José $u Chemistry Department, University of Burgos, Pza. Misael Bañuelos s/n, 09001 Burgos, Spain
- 700 1_
- $a Cuevas, José Vicente $u Chemistry Department, University of Burgos, Pza. Misael Bañuelos s/n, 09001 Burgos, Spain
- 700 1_
- $a Herrera, Antonio $u Molecular Biology Institute of Barcelona, IBMB-CSIC, 08028 Barcelona, Spain
- 700 1_
- $a Mergny, Jean-Louis $u ARNA Laboratory, INSERM U1212, CNRS UMR 5320, IECB, University of Bordeaux, F-33600 Pessac, France; Institute of Biophysics, AS CR, v.v.i. Kralovopolska 135, 612 65 Brno, Czech Republic; Laboratoire d'optique et Biosciences, Ecole Polytechnique, CNRS, Inserm, Institut Polytechnique de Paris, Palaiseau, France
- 700 1_
- $a Pons, Sebastian $u Molecular Biology Institute of Barcelona, IBMB-CSIC, 08028 Barcelona, Spain
- 700 1_
- $a Torroba, Tomás $u Chemistry Department, University of Burgos, Pza. Misael Bañuelos s/n, 09001 Burgos, Spain
- 700 1_
- $a García, Begoña $u Chemistry Department, University of Burgos, Pza. Misael Bañuelos s/n, 09001 Burgos, Spain
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 108, č. - (2021), s. 104660
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33550073 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145139 $b ABA008
- 999 __
- $a ok $b bmc $g 1751881 $s 1155712
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 108 $c - $d 104660 $e 20210128 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20220113